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RACUMIN PLUS~, A NEW PROMISING RODENTICIDE AGAINST RA TS AND MICE 
REINER POSPISCHIL, Institute of Parasitology, Bayer AG, D-51368 Leverkusen, Germany. 
HANS-JURGEN SCHNORBACH, Institute for Pest Control, Bayer AG, D-51368 Leverkusen, Germany. 
ABSTRACT: Coumatetralyl (Racumin •) bas been known since 1957 as a multiple dose anticoagulant and bas been used 
successfully over many decades. In the seventies and especially the eighties, rats developed an increased resistance to 
anticoagulants in certain regions of Central Europe. Also, the addition of vitamin K to animal feed (especially to 
chicken feed) bas reduced the effiC3cy against rats and mice in farm buildings. Combinations of anticoagulants with 
different types of vitamin D are generally described to increase the efficacy of action against rodents. It was found that 
especially the combination of coumatetralyl with cholecalciferol (vitamin D3) could overcome the above mentioned 
problems. Cbolecalciferol causes hypercalcemia and, therefore, bas a different mode of action compared to 
anticoagulants. The combination of these active ingredients leads to an obvious increase in efficacy against rodents, even 
under difficult conditions. The formulation with optimal rodenticidal efficacy contains 0.04 % coumatetralyl and 0.025 % 
cholecalciferol mixed in rolled oats. 
INTRODUCTION 
Anticoagulants are the most important rodenticides 
worldwide. Multiple dose anticoagulants have been in use 
since the early 1950s. In the 1970s the so called •single 
dose anticoagulants• were evaluated. Besides this mode 
of action, the hypercalcemia~using agents calciferol and 
cbolecalciferol came into use, particularly for the control 
of mice. 
In the 1970s and 1980s rats developed an increased 
resistance to anticoagulants in certain areas worldwide 
(Greaves 1985, 1986; MacNicoll 1982). Also, vitamin K 
containing feed (e.g., maiz.e and chicken feed) caused 
severe problems in some places. 
This paper describes a combination of coumatetralyl 
and cholecalciferol which overcomes these problems. 
METHODS 
Study Animals 
The tests were carried out with two strains of the 
Norway rat (Ra11us norvegicus) and the house mouse (Mus 
musculus). 
The albino strain of R. norvegicus belongs to the 
WIST AR strain. The wild rats are from a laboratory 
breeding in our institute. The parental generation of these 
rats was captured in the environment of Leverkusen 
(Germany). 
Choice Tests with Albino Rats 
Pairs of rats housed together in type III macrolon 
cages were offered 50 g of the test forinulation and 50 g 
of the premix formulation (e.g., rolled oats or shredded 
wheat) every day for six consecutive days. The sides 
from which the food variants were offered were switched 
daily, to compensate for any •side• influences. The 
quantities of feed eaten were determined each day by 
weighing. Drinking water was available ad libitum. 
Choice Test with Wild Rats 
Norway rats housed individually in metal cages were 
offered 30 g of the test formulation and 30 g of the 
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premix formulation every day for four consecutive days. 
The sides from which the food variants were offered were 
switched daily, to compensate for any •side• influences. 
The quantities of feed eaten were determined each day by 
weighing. Drinking water was available ad libitum. 
Choice Test According to the Guidelines of the German 
Registration Authorities CBBA Braunschweig. Germany) 
with Albino or Wild Rats CBBA 1983) 
The tests were carried out in small pens which consist 
of three chambers in tandem arrangement connected by 
small loop-holes. Each chamber is one square meter in 
siz.e. One chamber serves as a •Jiving room• for the rats 
and contains a nestbox with hay and cellulose as nesting 
material. The second chamber is empty and serves as a 
runway and the third chamber contains the test bait, the 
untreated feed and the water source. The drinking water 
is available ad libitum. 
The rats were acclimatiz.ed to the pens for two days. 
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Over this period they were fed with a standard diet 
(altromin 0). Over the following four days they received 
100 g of the test formulation and 100 g of the premix 
formulation. The sides from which the food variants 
were offered were switched daily, to compensate for any 
•side• influences. The quantities of feed eaten were 
determined each day by weighing. 
The choice tests with Mus musculus (wild strain) were 
carried out using similar methods. 
Active Ingredients and Bait Formulations Coumatetralyl 
(Table 1) 
Coumatetralyl has been known since 1957 and 
belongs to the class of •multiple dose• anticoagulants. Its 
efficacy is cbaracteriz.ed by a highly cumulative effect. 
In comparison to the so~lled •single dose• 
anticoagulants the LD» of coumatetralyl for rats is high 
(16.5-30 mg a.i./kg body weight). After consumption 
over five consecutive days it increases considerably to 5 
x 0.3 mg/kg b.w. The house mouse is far less 
susceptible than the Norway rat to an acute dose of 
Table 1. LD50 of Coumatetralyl and Cholecalciferol against rats and mice. 
acute LD50 (mg a.i./kg body weight) 
Norway rat House mouse 
Coumatetralyl 
Cholecalciferol 
16.5-30 
43.6 
subacute LD50 
2000-4000 
42.5 
(mg a.i ./kg body weight) 
Norway rat House mouse 
(after 5 days consumption) (after 18 days consumptjon) 
Coumatetralyl 
Cholecalciferol 
5 x 0.3 
coumatetralyl (2000-4000 mg/kg b.w.). However, when 
given over a longer period, e.g., over 18 consecutive 
days, the LD50 is reduced to 18 x 3.S mg/kg b.w. 
The mode of action of anticoagulants, e.g., 
Coumatetralyl, is described well by Meehan 1984 and 
Schnorbach 1993. 
Cholecalciferol (Table 1) 
Cholecalciferol has an acute to subacute mode of 
action. Applied in physiologically high doses, 
cholecalciferol (vitamin D3) shows good rodenticidal 
properties. Cholecalciferol is responsible for the transport 
of calcium from the feed through the intestinal membranes 
into the blood. In addition, it is involved in the bone 
formation. In unphysiologically high doses it leads to a 
massive disturbance of the calcium exchange system. 
Calcium concentrates itself in the blood and various 
organs (e.g., kidneys, heart, lungs and the vascular 
system). Kidney failure is generally the cause of death. 
The LD50 in Norway rats is 43.6 mg/kg b.w. and 
42.5 for house mice. Further information on 
cholecalciferol is given in Greaves 1974, Lund 1988, 
Marshall 1984 and Schnorbach 1993. 
Bait Formulations 
Under European conditions, baits based on debittered 
oat flakes or roughly shredded or broken wheat proved to 
be most successful. The tests were carried out with these 
basic foodstuffs. 
RESULTS AND DISCUSSION 
Laboratory Tests 
Combinations of anticoagulants with different types of 
vitamin D are generally described to increase the efficacy 
of action against rodents (Hadler 1973). 
It was found in our laboratory that, in particular, the 
combination of coumatetralyl and cholecalciferol could 
overcome the inefficacy of anticoagulants caused by 
resistance or vitamin K-containing food (Fuhrmann 1991, 
Lund 1991, Schnorbach 1992). A number of 
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18 x 3.5 
combinations of 0.02 to 0.04% coumatetralyl and 0.01 to 
0.1 % cholecalciferol have been tested (Tables 2 to 6). 
Due to its subacute delayed mode of action coumatetralyl 
(0.04%) cannot achieve 100% mortality after one day of 
feeding (Table 2); 0.1 % cholecalciferol alone is also not 
suitable to control a rat population with only one day of 
feeding, and often the poor acceptance is a result of bait 
shyness (Table 3). However, the combination of both 
active ingredients results in the same acute effects with 
delayed actions as we are accustomed to seeing in cases 
of single-dose anticoagulants. In contrast to these 
anticoagulants, the symptoms start earlier after 
consumption of Racumin plus. In combination with 
cholecalciferol, the amount of coumatetralyl should not be 
less than 0.04% but the percentage of cholecalciferol can 
be diminished to 0.025% or even 0.01 % to avoid bait 
shyness (Prescott et al. 1992) (Tables 4 to 6). 
The combination with optimal rodenticidal efficacy 
(coumatetralyl 0 .04 %/cholecalciferol 0.025 %) was 
thoroughly tested in the laboratory and outdoors under the 
name "Racumin plus" in several bait formulations based 
on rolled oats, roughly shredded wheat or broken wheat. 
Some representative results are shown in the following 
sections. 
In a choice test carried out according to the BBA 
guidelines (BBA 1983) Racumin plus was accepted well 
by rats in comparison to untreated rough shredded wheat 
(Figure 1). The feeding behavior was typical for single-
dose rodenticides with delayed action. However, in 
comparison to single-dose anticoagulants the time to death 
was two to four days. After two days feeding, the 
amount of consumed bait declined sharply and from the 
fourth day on the rats stopped feeding. The first rats died 
on the third day and after six days we reached 100% 
mortality. Similar results are shown in Figure 2 with a 
wild strain of the house mouse. The bait consumption 
declined sharply after the second day. The mortality 
started after three days and ended with 100% on the 
eighth day. 
Acceptance of Racumln plus by Rattus norveglcus 
In comparison to rough shredded wheat 
• test according to the BBA· guide lines 
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Figure 1. Acceptance of Racumin plus by Rallus norvegicus in 
comparison to rough shredded wheat-test according to the BBA-
guidelines. 
Efficacy of Racumln plus against the house mouse Mua muscufus 
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Figure 2. Efficacy of Racumin plus against the house mouse 
(Mus musculus) in a choice test in comparison to untreated 
wheat. 
Table 2: Efficacy of a Racumin ready to use bait (0.0375 % coumatetralyl} against Rattus norvegicus. 
length of food- active delayed mortality 
feeding a/w consumption ingredient mortality min-max average 
~da;p} ~g) ms/ks b.w. 
' 1 a x = 11.8 x = 26.8 6 / 10 s - 12 8.2 
s = 1.7 s = 4.1 
1 w x = 22.3 x = 35.4 20 / 48 3 - 8 s.o 
s = 8.2 s = 8.6 
2 a x = IS.I x = 34.9 5 / 10 5-8 6.0 
s = 3.3 s = 7.8 
2 w x = 35.8 x = 68.0 7/8 2 - 12 7.0 
s = 16.9 s = 25.S 
5 a x = 29.1 x = 66.S 10 / 10 4 - 10 6.2 
s = S.5 s = 14.2 
5 w x = 34.2 x = 72.0 10 / 10 4-8 6.3 
s = 11.2 s = 32.9 
x =average; s = standard deviation 
a = albino strain of Ranus norvegicus 
w = wild strain of Ra1tus norvegicus 
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Table 3. Efficacy of a Muritan ready to use bait (0.1 % cholecalciferol) against Ra11us norvegicus. 
length of food- active delayed mortality 
feeding a/w consumption ingredient mortality min-max average 
(days) (g) mg/kg b.w. 
1 a X= 7.9 x= 40.3 11 / 20 3 - 14 5.2 
s = 3.0 s = 16.2 
1 w X= 16.5 x= 71.6 8 / 10 2 - 12 6.8 
s = 5.8 s = 23.3 
2 a x= 12.S x= 61.9 10 I 10 3-6 4.0 
s = 3.5 s = 17.S 
2 w x = 18.9 x= 100.2 8 / 10 4-9 7.0 
s = 9.2 s = 47.3 
x = average; s = standard deviation 
a = albino strain of Ra11us norvegicus 
w = wild strain of Ra11us norvegicus 
Aging at room temperature over two years did not 
affect the acceptance and efficacy of Racumin plus in 
comparison to a sample which was frozen at minus 25°C 
over the same period (Figure 3). 
n • 10 rats (1lblno.traln ) 
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Figure 3. Acceptance of Racumin plus by RaltllS norvegic1lS 
after 24 month aging. 
In the Miinsterland area (Gennany), Norway rats 
were captured in farms with severe rat problems caused 
in part· by anticoagulant resistance. After an 
'llCClimati2'.8tion period of four weeks, 27 rats were tested 
against coumatetralyl and 10 surviving individuals were 
observed for another eight weeks. They were then fed 
with Racumin plus and died within two weeks (Figure 4). 
Due to this promising result, field tests were carried out 
with Racumin plus in three farms of the Miinsterland area 
with resistance problems (Figure S). The extent of the rat 
infestation was ascertained with untreated rolled oats. 
After one week the oats were exchanged for Racumin 
plus. The bait was well accepted in the beginning. From 
the third week on, the consumption of bait decreased 
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sharply and there were no further signs of rat infestation. 
After a period of seven weeks untreated rolled oats were 
again offered to determine the efficacy of the treatment. 
The renewed feeding activity was a result of reinfestation 
from surrounding farms which were also heavily infested 
by rats. 
date of capture 0 iiiiiiiiiiiiiiiiiitl 
' 
2 
Test with 
coumatetralyl 0.0375 % 6 
' 
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Test with 10 
Racumln plus 
' 
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14 
0 
Acclimatization 4 weeks 
ts 
5 10 15 20 25 30 35 
Figure 4. Efficacy of Racumin plus against coumatctralyl-
resistant Norway rats . 
In a chicken farm near Leverkusen (Germany), where 
anticoagulants were not effective because of vitamin K-
containing feed, a control program was conducted with 
Racumin plus. Bait acceptance and control of the rats 
was viewed positively by the farmer. Rats which were 
captured before the test did not show signs of resistance 
against anticoagulants after an incubation period of 
several weeks, indicating that the antidote content in the 
chicken feed was the real problem at this farm. 
Table 4a. Efficacy of a ready to use bait based on 0.02 % coumatetralyl and 
0.05% cholecalciferol against Ra11us norvegicus. 
length of food- delayed mortality 
feeding alw consumption mortality min-max average 
(days) (g) 
. 1 a x = 15.5 12 / 12 3 - 6 4.3 
s = 2.5 
1 w x = 19.2 11/12 3-5 3.9 
s = 8.3 
2 a x = 15.8 12 / 12 3-7 3.7 
s = 8.3 
2 w x = 27.9 12 / 12 3-4 3.4 
s = 9.4 
x =average; s = standard deviation 
a = albino strain of Rartus norvegicus 
w = wild strain of Rattus norvegicus 
Table 4b. Laboratory test according to the BBA guidelines: Ready to use bait (0.02 % 
coumatetralyl/0.05% cholecalciferol) against untreated rough shredded wheat. 
consumed bait mortality delayed mortality 
g/7 days min-max average 
1. Test 
bait 98.3 7 I 8 3-5 3.7 
untreated wheat 216.6 
low bait shyness 
2. Test 
bait 86.0 10 / 10 3-5 4.6 
untreated wheat 255.0 
low bait shyness 
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Table Sa. Efficacy of Racumin plus (0.04% coumatetralyl/0.025% cholecalciferol) 
against Rattus norvegicus. 
length of food- delayed mortality 
feeding a/w consumption mortality min-max average 
(days) (g) 
1 a x = 14.6 6/6 2-4 3.0 
s = 1.9 
1 w x = 21.4 12 I 12 3 - 9 S. 1 
s = 9.1 
2 a x = 20.7' 616 2-3 2.7 
s = 2.4 
2 w x = 31.S 12 / 12 3-S 4.0 
s = 11.2 
x =average; s = standard deviation 
a = albino strain of Rattus norvegicus 
w = wild strain of Rattus norvegicus 
Table Sb. Laboratory test according to the BBA guidelines: Racumin ready to use bait 
(0.04% coumatetralyl and 0.025% cholecalciferol) against untreated rough shredded 
wheat. 
consumed bait mortality delayed mortality 
g/7 days min-max average 
1. Test 
bait 320.0 12 / 12 3-6 4.7 
untreated wheat 390.3 
no bait shyness 
2. Test 
bait 144.6 10 I 10 2-S 4. 1 
untreated wheat 322.4 
no bait shyness 
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Table 6a. Efficacy of a ready to use bait based on 0.04% coumatetralyl/0.01 % 
cholecalciferol) against Rattus norvegicus. 
length of food- delayed mortality 
feeding a/w consumption mortality min-max average 
(days) (g) 
1 a x = 15.6 616 3-5 3.8 
s = 1.4 
1 w x = 18.9 616 5-7 5.7 
s = 6.2 
2 a x = 24.8 616 3-4 3.7 
s = 2.6 
2 w x = 29.7 616 4-5 4.2 
s = 3.5 
x =average; s = standard deviation 
a = albino strain of Raltus norvegicus 
w = wild strain of Rclltus 11orvegicus 
Table 6b. Laboratory test according to the BBA guidelines: Ready to use bait (0.04% 
coumatetralyl and 0.01 % cholecalciferol) against untreate4 rough shredded wheat. 
bait 
consumed bait 
g/7 days 
175.4 
untreated wheat 179 .1 
no bait shyness 
consumption of bait (g) 
I Ofann1•tarm2 •tarm 31 
150 
100 1--- -- - - -
50 
.. 5 6 
ORI trNtment DE 
ORI Determination of rat infestation (flaked oats) 
DE Determination of efficacy (ftaked oats) 
Figure S. Field test with Racumin plus in three fanns 
(Miinstcrland, Germany) with anticoagulant-resistant rats 
(Ranus norv!gicus). 
mortality delayed mortality 
min-max average 
10 / 10 3-6 4.4 
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Table 7 gives a short summarized characterii.ation of 
the two active ingredients coumatetralyl and 
cholecalciferol. Coumatetralyl exhibits good efficacy 
against rats and does not show development of any bait 
shyness because of its delayed action. As a multiple dose 
anticoagulant it is relatively safe for the user. The low 
efficacy against mice is improved by cholecalciferol. 
Problems due to resistance to anticoagulants or vitamin K-
containirig feed can also be overcome by cholecalciferol. 
Fast-acting cholecalciferol may cause bait shyness in 
higher doses (more than 0 .05%). The combination with 
coumatetralyl allows a reduction of the cholecalciferol 
concentration to avoid bait shyness. Accidental poisoning 
with cholecalciferol can be treated symptomatically with 
dexamethasone or furosemide. The treatment with 
Calcitonin is problematic because of its short half-life of 
less than IS minutes in the human body. The described 
combination of the multiple dose anticoagulant 
coumatetralyl with the hypercalcemia-causing agent 
cholecalciferol in an attractive bait formulation is a good 
agent for modem rodent control even under difficult 
conditions caused by resistance problems or antidote 
containing foodstuffs. 
Table 7. Cbaracteri7.ation of coumatetralyl and 
cbolecalciferol. 
Coumatetnllyl Cholecalclferol 
chemlQI 3 -(alpha-~ -4- (3 beUl,5 cia, 7 trlnl)-
name ~IMM 9, 1 ~lllCDCholnla-5,7,10(19~ 
etruc:tu111I $B HOaM fonnula 
active 
Ingredient 4-hydroxycumarin Vrtamin-0-complex 
group 
mode of anticoagulanl hypercaloemla action 
good -.cy "'"'not ma no IMlteaoca ptOlllems 
benefits nobd.,,,._ -19M*rll-
-· 
Olfolppllcdon 
dlsad· --· ...... ...... c:eu- bllil shyness 
vantag• 1n-p1aceo-nco. 
ptOlll- In doles> 0.05% 
entldote/ Dexamethasone 
aympto· VrtaminK Furosemlde 
matlc (Calcitonln) therepy 
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